Biorecognition Engineering Technologies for Cancer Diagnosis: A Systematic Literature Review of Non-Conventional and Plausible Sensor Development Methods.

Cancers (Basel) · 2022 · PMC9030888 · PMID 35454775

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

The number of articles about cancer biosensors and antibody mimetic molecules had an increasing trend from 2004 to 2018, recombinant antibodies from 2014 to 2017, and molecularly imprinted polymers from 2013 to 2016.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.